首页|组织蛋白酶在神经系统变性疾病中的研究进展

组织蛋白酶在神经系统变性疾病中的研究进展

扫码查看
组织蛋白酶是溶酶体中最为丰富的水解酶,负责降解各种底物.目前,越来越多的证据表明,组织蛋白酶在神经系统变性疾病中发挥重要作用.组织蛋白酶通过调节异常蛋白的聚集(α-突触核蛋白、β-淀粉样蛋白、亨廷顿蛋白等)影响疾病的进展,尤其是神经系统中组织蛋白酶B、D、L等的表达及活性异常、基因突变可以导致神经系统变性疾病的发生发展.本文总结了近年来组织蛋白酶在神经系统变性疾病中的研究进展,以期为神经系统变性疾病的早期诊断及治疗提供依据.
Research progress of cathepsins in neurodegenerative diseases
Cathepsins,the most abundant hydrolases in lysosomes,are responsible for the degradation of various substrates.Increasing evidence suggests that cathepsins play important roles in neurodegenerative diseases.Cathepsins affect the progression of diseases by regu-lating the aggregation of abnormal proteins(e.g.α-synuclein,amyloid β-protein,huntington).Abnormal expression levels and activity and gene mutations of cathepsin B,D,and L in the nervous system can lead to the occurrence and development of neurodegenerative diseases.This review summarizes the research progress on cathepsins in neurodegenerative diseases in recent years,with a view to providing a basis for the early diagnosis and treatment of these diseases.

cathepsinneurodegenerative diseaseresearch progress

姚思彤、徐薇淇、丛树艳

展开 >

中国医科大学附属盛京医院神经内科,沈阳 110004

组织蛋白酶 神经系统变性疾病 研究进展

2024

中国医科大学学报
中国医科大学

中国医科大学学报

CSTPCD北大核心
影响因子:1.421
ISSN:0258-4646
年,卷(期):2024.53(11)